Research Topics
Genomes and Genes | Stefano GoldwurmSummaryAffiliation: Istituti Clinici di Perfezionamento Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L Destefano
Department of Biostatistics, Boston University School of Public Health, 715 Albany Street, Crosstown Center, 3rd Floor, Boston, MA 02118, USA
Hum Genet 124:95-9. 2008..This replication of association with rs967582 in a third cohort further implicates ELAVL4 as a PD susceptibility gene...
Genomewide association study for onset age in Parkinson diseaseJeanne C Latourelle
Boston University School of Medicine, Boston, MA, USA
BMC Med Genet 10:98. 2009..There have been previous genomewide association studies (GWAS) to identify genes influencing PD susceptibility, but this is the first to identify genes contributing to the variation in onset age...
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle
Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
BMC Med 6:32. 2008..Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD...
Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson diseaseS Goldwurm
Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy
Neurology 68:1141-3. 2007..The cumulative incidence of the disease was 15% at 60 years, 21% at 70 years, and 32% at 80 years. This study provides accurate estimates of G2019S penetrance by minimizing the selection bias...
LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sampleStefano Goldwurm
Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy
Parkinsonism Relat Disord 12:410-9. 2006..Clinical features in carriers were those of typical, idiopathic Parkinson's disease. However, behavioural abnormalities were frequent (87%), suggesting a more widespread limbic involvement in G2019S carriers...
SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian populationLuca Trotta
Dipartimento di Biologia e Genetica per le Scienze Mediche, Universita degli Studi di Milano, Milan, Italy
Parkinsonism Relat Disord 18:257-62. 2012..An evaluation of gene-gene and gene-environment interactions in association with PD was also attempted...
Screening for the presence of FMR1 premutation alleles in women with parkinsonismRoberto Cilia
Parkinson Institute Clinici di Perfezionamento, Milan, Italy
Arch Neurol 66:244-9. 2009..The presence of parkinsonism in FXTAS raises the possibility that some individuals who have Parkinson disease are actually carriers of a premutation FMR1 allele...
Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutationIoannis U Isaias
Centro Parkinson, Istituti Clinici di Perfezionamento, Milan, Italy
Mov Disord 21:1144-7. 2006..We conclude that in these patients carrying the LRRK2 Gly2019Ser mutation, the neurodegenerative process results in a pattern of nigrostriatal dopaminergic dysfunction similar to that observed in IPD...
Parkin analysis in early onset Parkinson's diseaseFrancesca Sironi
Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy
Parkinsonism Relat Disord 14:326-33. 2008..735delT (p.C212/X224) and c.815C>G (p.C238W). Genotype-phenotype correlation revealed that parkin carriers had features similar to those of non-carrier early onset Parkinson disease patients...
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onsetAndrea Panzacchi
Department of Nuclear Medicine, Scientific Institute San Raffaele, Milan, Italy
Neurobiol Dis 31:102-9. 2008..This work demonstrates that severity of nigrostriatal damage in early disease phase of sporadic PD is not dependent on age at onset. Genetically determined PD is associated with more severe and widespread dopaminergic impairment...
Psychiatric symptoms in Parkinson's disease assessed with the SCL-90R self-reported questionnaireChiara Siri
Parkinson Institute, Istituti Clinici di Perfezionamento, Via Bignami, 1, 20123, Milan, Italy
Neurol Sci 31:35-40. 2010..Psychopathological features are frequent in PD and their occurrence is underlined by disease-related factors...
alpha-Synuclein multiplication analysis in Italian familial Parkinson diseaseFrancesca Sironi
Parkinson Institute, Istituti Clinici di Perfezionamento, Via Bignami 1, 20126 Milan, Italy
Parkinsonism Relat Disord 16:228-31. 2010..Although SNCA duplication is an unusual cause of familial PD testing for it is worthwhile. The clinical presentation of duplicated cases may be more aggressive than usual...
Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease geneIlaria Guella
Dipartimento di Biologia e Genetica per le Scienze Mediche, Universita degli Studi di Milano, Milan, Italy
Neurobiol Aging 32:1994-2005. 2011..These data, together with those recently reported by other groups, suggest that GIGYF2 is unlikely to be the PARK11 gene...
Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegenerationAngelo Antonini
Parkinson Institute and Neuroradiology, Istituti Clinici di Perfezionamento, Milan, Italy
Mov Disord 21:417-8. 2006..These findings expand the genetic and imaging spectrum of this rare disorder...
Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblastsDaniele Cartelli
Department of Biology, University of Milan, Milan, Italy
PLoS ONE 7:e37467. 2012....
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in ItaliansDaniele Ghezzi
Unit of Molecular Neurogenetics, National Neurological Institute, Carlo Besta, Milan, Italy
Eur J Hum Genet 13:748-52. 2005..Our study suggests that haplogroup K might confer a lower risk for PD in Italians, corroborating the idea that the mitochondrial oxidative phosphorylation pathway is involved in the susceptibility to idiopathic PD...
Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patientsEmanuela Castiglioni
Genomic Unit for the Diagnosis of Human Pathologies, Center for Genomics, Bioinformatics, and Biostatistics, San Raffaele Scientific Institute, Milan, Italy
Genet Test Mol Biomarkers 14:793-6. 2010..07). The analysis suggests that sequence variations in the coding region of FtMt are not involved in the development of myelodysplastic syndromes and Parkinson's disease...
Analysis of ferritin genes in Parkinson diseaseBarbara Foglieni
Unit of Genomics for Diagnosis of Human Pathologies, San Raffaele Scientific Institute, Milan, Italy
Clin Chem Lab Med 45:1450-6. 2007..The ferritin L-chain is one of these genes, but the rare insertional mutations that cause neuroferritinopathy with basal ganglia degeneration have not yet been identified in PD...
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyDaniel G Healy
Department of Clinical Neurosciences, Institute of Neurology, University College London, London, UK
Lancet Neurol 7:583-90. 2008..LRRK2-associated PD be distinguished from idiopathic PD; which mutations in LRRK2 are pathogenic; and what is the age-specific cumulative risk of PD for individuals who inherit or are at risk of inheriting a deleterious mutation in LRRK2?..
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's diseaseAlessio Di Fonzo
Department of Clinical Genetics, Erasmus MC Rotterdam, PO Box 1738, 3000 DR Rotterdam, Netherlands
Lancet 365:412-5. 2005..The associated phenotype was broad, including early and late disease onset. These findings confirm the association of LRRK2 with neurodegeneration, and identify a common mutation associated with dominantly inherited Parkinson's disease...
HFE gene mutations in a population of Italian Parkinson's disease patientsGiorgio Biasiotto
Dipartimento Materno Infantile e Tecnologie Biomediche, University of Brescia, Viale Europa 11, 25123 Brescia, Italy
Parkinsonism Relat Disord 14:426-30. 2008..We conclude that in the Italian population, the most common HFE mutations, H63D and C282Y are not associated with the individual risk to develop PD, nor have specific influence on the clinical features of the disease...
Screen for excess FMR1 premutation alleles among males with parkinsonismJeremy Kraff
Department of Biochemistry and Molecular Medicine, University of California, Davis, School of Medicine, One Shields Avenue, Davis, CA 95616, USA
Arch Neurol 64:1002-6. 2007..Parkinson disease populations may thus include individuals who harbor premutation expansions (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene...
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD studyMei Sun
Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Arch Neurol 63:826-32. 2006..The PARK2 gene at 6q26 encodes parkin, whose inactivation is implicated in an early-onset autosomal recessive form of Parkinson disease (PD)...
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's diseaseAlessio Di Fonzo
Department of Clinical Genetics, Erasmus MC Rotterdam, Rotterdam, The Netherlands
Eur J Hum Genet 14:322-31. 2006..These data have implications both for understanding the molecular mechanisms of PD, and for directing the genetic screening in clinical practice...
Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesisAnne Grünewald
Department of Neurology, University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
Neurogenetics 8:103-9. 2007..1366C>T mutation...
Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrumRoberta Marongiu
IRCCS CSS Mendel Institute, Rome, Italy
Hum Mutat 28:98. 2007..15445_15467del23) which produces several aberrant mRNAs. This report expands the genotypic spectrum of PINK1 mutations, with relevant implications for molecular analysis of this gene...
Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson diseaseCorinne Lautier
Division of Endocrinology, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA
Am J Hum Genet 82:822-33. 2008..The earlier onset and severe clinical course in the index patient suggest additive effects of the GIGYF2 and LRRK2 mutations. These data strongly support GIGYF2 as a PARK11 gene with a causal role in familial PD...
